Compounds > methotrexate
Page last updated: 2024-08-25

methotrexate and Chronic Progressive Multiple Sclerosis

methotrexate has been researched along with Chronic Progressive Multiple Sclerosis in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cyphert, J; Schwetz, KM; Wineman, NM; Zeller, R1
Hartung, HP; Kieseier, BC1
Forbes, RB; Gray, O; McDonnell, GV1
Ahmed, A; Ali, S; Asif, M; Fredrikson, S; Haq, A; Hassan, A; Khatri, IA; Khealani, B; Malik, A; Wasay, M; Zakiullah, N1
Bonanni, L; Caporale, C; De Luca, G; Farina, D; Gambi, D; Iarlori, C; Lugaresi, A; Marzoli, F; Muraro, PA1
Lublin, FD1

Reviews

3 review(s) available for methotrexate and Chronic Progressive Multiple Sclerosis

ArticleYear
Current disease-modifying therapies in multiple sclerosis.
    Seminars in neurology, 2003, Volume: 23, Issue:2

    Topics: Adjuvants, Immunologic; Analgesics; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Cyclophosphamide; Cyclosporine; Glatiramer Acetate; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Interferon-beta; Methotrexate; Mitoxantrone; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Peptides; Plasma Exchange

2003
Methotrexate for multiple sclerosis.
    The Cochrane database of systematic reviews, 2004, Issue:2

    Topics: Humans; Immunosuppressive Agents; Methotrexate; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Randomized Controlled Trials as Topic

2004
Therapeutic approaches to secondary progressive multiple sclerosis.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2002, Volume: 8, Issue:1

    Topics: Anti-Inflammatory Agents; Azathioprine; Bone Marrow Transplantation; Cladribine; Clinical Trials as Topic; Cyclosporine; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Interferon beta-1a; Interferon beta-1b; Interferon-beta; Methotrexate; Methylprednisolone; Mitoxantrone; Multiple Sclerosis, Chronic Progressive

2002

Trials

2 trial(s) available for methotrexate and Chronic Progressive Multiple Sclerosis

ArticleYear
Longitudinal analysis of illness uncertainty, coping, hopefulness, and mood during participation in a clinical drug trial.
    The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses, 2003, Volume: 35, Issue:2

    Topics: Adaptation, Psychological; Adult; Affect; Aged; Female; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Methotrexate; Middle Aged; Multiple Sclerosis, Chronic Progressive; Randomized Controlled Trials as Topic; Sick Role

2003
Low-dose oral methotrexate treatment in chronic progressive multiple sclerosis.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:2

    Topics: Adult; Dose-Response Relationship, Drug; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Methotrexate; Middle Aged; Multiple Sclerosis, Chronic Progressive; Treatment Outcome

2001

Other Studies

1 other study(ies) available for methotrexate and Chronic Progressive Multiple Sclerosis

ArticleYear
Multiple sclerosis in Pakistan.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2007, Volume: 13, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents; Female; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-beta; Male; Methotrexate; Middle Aged; Mitoxantrone; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Optic Neuritis; Pakistan; Prevalence; Retrospective Studies; Steroids

2007